FindMyKOL

Raul Weiss, MD

Enriched profile

Director of the William E. & Molly Ford Cardiac Electrophysiology Center · Mount Sinai Medical Center

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Miami Beach, FL · Southeast · United StatesSpecialtyClinical Cardiac ElectrophysiologyFocusCardiac pacing and defibrillation studies+4
Active KOLFindMyKOL type: EliteLatest publication2024Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Raul Weiss is Director of the William E. & Molly Ford Cardiac Electrophysiology Center at Mount Sinai Medical Center. OpenAlex indexes 189 publications with 8,881 citations (h-index 46); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Clinical Cardiac Electrophysiology profiles in the FindMyKOL directory.

Data verified 18 Oct 2026

Overview

Updated 3 Nov 2026

Raul Weiss, M.D., is Director of the William E. & Molly Ford Cardiac Electrophysiology Center at Mount Sinai Medical Center. The public record shows 189 publications with 8,881 citations (h-index 46), centered on Cardiac pacing and defibrillation studies, Cardiac electrophysiology and arrhythmias, Cardiac Arrhythmias and Treatments. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 25 companies.

  • Most recent indexed publication: 2024 · Circulation. Arrhythmia and electrophysiology
  • Top research focus: Cardiac pacing and defibrillation studies
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 3 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Atrial Fibrillation2 trialsHeart Failure2 trialsTachycardia, Ventricular2 trialsTachycardia2 trialsPica1 trialArrhythmias, Cardiac1 trialVentricular Fibrillation1 trial

Research focus

OpenAlex concept fingerprint
Cardiac pacing and defibrillation studiesCardiac electrophysiology and arrhythmiasCardiac Arrhythmias and TreatmentsAtrial Fibrillation Management and OutcomesCardiac Arrest and Resuscitation

Drugs & molecules

across trials, industry payments and publications
SotalolClinical trials—Industry payments7Publications—Xareltogeneric · RivaroxabanClinical trials—Industry payments7Publications—Eliquisgeneric · ApixabanClinical trials—Industry payments4Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments2Publications—Attrubygeneric · AcoramidisClinical trials—Industry payments1Publications—Camzyosgeneric · MavacamtenClinical trials—Industry payments1Publications—Leqviogeneric · InclisiranClinical trials—Industry payments1Publications—Multaqgeneric · DronedaroneClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Biosense Webster, Inc.Clinical trials1Industry payments13Abbott LaboratoriesClinical trials—Industry payments116Boston Scientific CorporationClinical trials—Industry payments90Biotronik Inc.Clinical trials—Industry payments62Impulse Dynamics (USA) Inc.Clinical trials—Industry payments18Medtronic, Inc.Clinical trials—Industry payments15Ancora Heart, Inc.Clinical trials—Industry payments8Atricure, Inc.Clinical trials—Industry payments8ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments8AltaThera Pharmaceuticals LLCClinical trials—Industry payments7Janssen Pharmaceuticals, IncClinical trials—Industry payments7E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments4Novartis Pharmaceuticals CorporationClinical trials—Industry payments3Abbott Medical DevicesClinical trials2Industry payments—Philips North America LLCClinical trials—Industry payments2AtaCor Medical, Inc.Clinical trials1Industry payments—Baxter HealthcareClinical trials—Industry payments1BridgeBio Pharma, Inc.Clinical trials—Industry payments1Catheter Precision Inc.Clinical trials—Industry payments1Impulse DynamicsClinical trials1Industry payments—Inspire Medical Systems, Inc.Clinical trials—Industry payments1iRhythm Technologies, Inc.Clinical trials—Industry payments1Kestra Medical Technology Services, Inc.Clinical trials—Industry payments1Medical Device Business Services, Inc.Clinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1Sanofi-Aventis U.S. LLCClinical trials—Industry payments1StereotaxisClinical trials1Industry payments—Volta Medical IncClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
189publications

Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.

8,881citations

Total citations across indexed works.

46h-index

Hirsch index (OpenAlex). i10-index 87.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
25companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 3 Nov 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 3 Nov 2026

25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    64.7%
    Factor Xa inhibitor64.7%
    Eliquis100%
    Part D≥12 patients
  • Cardiovascular

    35.3%
    Beta blocker35.3%
    Metoprolol Succinate100%
    Part D≥11 patients
Where care is delivered (Part B)43.3% facility · 56.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 3 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 3 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Emile G. Daoud71John D. Hummel50Bradley P. Knight41Mahmoud Houmsse41Steven Jack Kalbfleisch40Ralph Sayre Augostini37Muhammad R. Afzal34Toshimasa Okabe27Martin C. Burke23Rajiva Goyal23K.Ching Man22S. Adam Strickberger22Jaret D. Tyler21Marwan Bahu20Barry London19Alaa A. Shalaby18Samuel C. Dudley17Michael Robert Gold16Rebecca A Gutmann16Vadim V. Fedorov15Mikhael F. El‐Chami15Peter J. Mohler15Patrick T. Ellinor14Pier David Lambiase13Heather Lynn Bloom13Paul M.L. Janssen13Frank Matthias Bogun12Brian J. Hansen11Thomas A. Csepe11Fred Morady10Cynthia A. Carnes10Marc A. Miller9Vladimir Shusterman9Johan D. Aasbo9Troy E. Rhodes9Ahmet Kılıç9Lucas V.A. Boersma9Michael K. Essandoh9Jichao Zhao8Adam H. Zivin8

Online presence

Updated 3 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    msmc.com/doctor/raul-l-weiss

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →msmc.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 3 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.